Skip to main content
Log in

A PvuII polymorphism in the 5′ flanking region of the apolipoprotein AIV gene: its use to study genetic variation determining serum lipid and apolipoprotein concentration

  • Original Investigations
  • Published:
Human Genetics Aims and scope Submit manuscript

Summary

We have used a 1.05-kb unique genomic fragment from the 5′ end of the apolipoprotein (apo) CIII gene to identify a restriction fragment length polymorphism (RFLP) detected with the restriction enzyme PvuII, in the apoCIII-apoAIV intergenic region. In a sample of 220 normolipidaemic individuals from the UK population, the frequency of the rare allele, VB2 is 0.054. The PvuII polymorphism is in apparent linkage equilibrium with three other RFLPs of this gene cluster, detected with the restriction enzymes XmnI, PstI and SstI, but in linkage disequilibrium with an RFLP in the apoCIII gene also detected with PvuII. Taken together, these five RFLPs have a PIC (polymorphism information content) value of 0.8, and therefore are informative for genetic studies. Individuals with the genotype VB1VB2 had lower mean concentrations of apoAI, and HDL-cholesterol than individuals with the genotype VB1VB1. However these differences were not statistically significant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Botstein D, White RL, Skolnick M, Davis RW (1980) Construction of a genetic linkage map using restriction fragment length polymorphisms. Am J Hum Genet 32:314–331

    Google Scholar 

  • Caerphilly, Speedwell Collaborative Group (1984) The Caerphilly and Speedwell Collaborative Heart Studies. J Epidemiol Community Health 38:259–262

    Google Scholar 

  • Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HK (1984) Nonuniform recombination within the human β-globin gene cluster. Am J Hum Genet 36:1239–1258

    Google Scholar 

  • Cohen T, Karathanasis SK, Kazazian HH Jr, Antonarakis SE (1986) DNA polymorphic sites in the human apoAI-CIII-AIV cluster: TaqI and AvaI. Nucleic Acids Res 14:1924

    Google Scholar 

  • Coleman RT, Gonzales PA, Funke H, Assman G, Levy-Wilson B, Frossard PM (1986) Polymorphisms in the apolipoprotein AI-CIII complex. Mol Biol Med 3:213–228

    Google Scholar 

  • Darnfors C, Nilsson J, Protter AA, Carlsson P, Talmud PJ, Humphries SE, Whalstroöm J, Wiklund O, Bjursell G (1986) RFLPs for the human apolipoprotein B gene: HincII and PvuII. Nucleic Acids Res 14:7135

    Google Scholar 

  • Frossard PM, Gonzalez PA, Protter AA, Coleman T, Hunke H, Assmann G (1986) PvuII RFLP in the 5′ of the human apolipoprotein B gene. Nucleic Acids Res 14:4373

    Google Scholar 

  • Humphries SE, Kessling AM, Horsthemke B, Donald JA, Seed M, Jowett NI, Holm M, Galton DJ, Wynn V, Williamson R (1985) A common DNA polymorphism of the low density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet I:1003–1005

    Google Scholar 

  • Kessling AM, Horsthemke B, Humphries SE (1985) A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet 28:296–306

    Google Scholar 

  • Kessling AM, Rajput J, Bainton D, Scott J, Miller N, Baker I, Humphries SE (1988) DNA polymorphisms of the apolipoprotein AII and AI-CIII-AIV genes: a study in men selected for differences in high density lipoprotein cholesterol concentration. Am J Hum Genet (in press)

  • Oettgen P, Antonarakis SE, Karathanasis SK (1986) PvuII polymorphic site upstream to the human apoCIII gene. Nucleic Acids Res 14:5571

    Google Scholar 

  • Ordovas JM, Schaefer EJ, Salem D, Ward RH, Glueck CJ, Vergani C, Wilson PWF, Karathanasis SK (1986) Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinaemia. N Engl J Med 314:671–677

    Google Scholar 

  • Rees A, Stocks J, Shoulders CC, Galton DJ, Barralle FE (1983) DNA polymorphism adjacent to human apoprotein AI gene: relation to hypertriglyceridaemia. Lancet I:444–446

    Google Scholar 

  • Rees A, Stocks J, Paul H, Ohuchi Y, Galton D (1986) Haplotypes identified by DNA polymorphisms at the apoA-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population. Hum Genet 72:168–171

    Google Scholar 

  • Seilhamer JJ, Protter AA, Frossard P, Levy-Wilson B (1984) Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI—discovery of a new genetic polymorphism in the apoAI gene. DNA 3:309–317

    Google Scholar 

  • Sing CF, Davignon J (1985) Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37:268–285

    Google Scholar 

  • Sokal RR, Rohlf FJ (1981) Biometry, 2nd edn. Freeman, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kessling, A.M., Taylor, R., Temple, A. et al. A PvuII polymorphism in the 5′ flanking region of the apolipoprotein AIV gene: its use to study genetic variation determining serum lipid and apolipoprotein concentration. Hum Genet 78, 237–239 (1988). https://doi.org/10.1007/BF00291668

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00291668

Keywords

Navigation